172 related articles for article (PubMed ID: 25301403)
1. Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
López-Gómez M; Moreno-Rubio J; Suárez-García I; Cejas P; Madero R; Casado E; Jiménez AM; Sereno M; Gómez-Raposo C; Zambrana F; Merino M; Fernández-Luengas D; Feliu J
Clin Transl Oncol; 2015 Apr; 17(4):322-9. PubMed ID: 25301403
[TBL] [Abstract][Full Text] [Related]
2. Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study.
Baba H; Baba Y; Uemoto S; Yoshida K; Saiura A; Watanabe M; Maehara Y; Oki E; Ikeda Y; Matsuda H; Yamamoto M; Shimada M; Taketomi A; Unno M; Sugihara K; Ogata Y; Eguchi S; Kitano S; Shirouzu K; Saiki Y; Takamori H; Mori M; Hirata T; Wakabayashi G; Kokudo N
Oncotarget; 2015 Oct; 6(32):34004-13. PubMed ID: 26372896
[TBL] [Abstract][Full Text] [Related]
3. Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.
Kobayashi H; Sugihara K; Uetake H; Higuchi T; Yasuno M; Enomoto M; Iida S; Azuma M; Mori R; Omori A; Lenz HJ; Danenberg KD; Danenberg PV
Int J Oncol; 2008 Dec; 33(6):1257-62. PubMed ID: 19020759
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.
Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallböhmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
Clin Cancer Res; 2006 Jan; 12(1):29-33. PubMed ID: 16397020
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Cell Proliferation and Vascular Endothelial Growth Factor Expression in Primary Colorectal Cancer and Corresponding Liver Metastases.
Raluca BA; Cimpean AM; Cioca A; Cretu O; Mederle O; Ciolofan A; Gaje P; Raica M
Asian Pac J Cancer Prev; 2015; 16(11):4549-53. PubMed ID: 26107202
[TBL] [Abstract][Full Text] [Related]
6. ERCC1 expression in advanced colorectal cancer and matched liver metastases.
Olsen LM; Fiehn AK; Hasselby JP
Pathol Res Pract; 2020 Mar; 216(3):152826. PubMed ID: 32008866
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analysis of paired primary colorectal carcinoma and liver metastases reveals fusion transcripts and similar gene expression profiles in primary carcinoma and liver metastases.
Lee JR; Kwon CH; Choi Y; Park HJ; Kim HS; Jo HJ; Oh N; Park do Y
BMC Cancer; 2016 Jul; 16():539. PubMed ID: 27461012
[TBL] [Abstract][Full Text] [Related]
8. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
Feiersinger F; Nolte E; Wach S; Rau TT; Vassos N; Geppert C; Konrad A; Merkel S; Taubert H; Stürzl M; Croner RS
PLoS One; 2016; 11(2):e0148580. PubMed ID: 26845148
[TBL] [Abstract][Full Text] [Related]
10. [Impact of preoperative drug therapy on the expression of angiogenesis markers in colorectal liver metastases].
Varlamov AV; Pal'tseva EM; Sekacheva MI; Skipenko OG; Fedorov DN
Arkh Patol; 2017; 79(1):36-42. PubMed ID: 28295006
[TBL] [Abstract][Full Text] [Related]
11. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
12. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.
Maus MK; Hanna DL; Stephens CL; Astrow SH; Yang D; Grimminger PP; Loupakis F; Hsiang JH; Zeger G; Wakatsuki T; Barzi A; Lenz HJ
Pharmacogenomics J; 2015 Aug; 15(4):354-62. PubMed ID: 25532759
[TBL] [Abstract][Full Text] [Related]
13. EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
Yarom N; Marginean C; Moyana T; Gorn-Hondermann I; Birnboim HC; Marginean H; Auer RC; Vickers M; Asmis TR; Maroun J; Jonker D
Cancer Biol Ther; 2010 Sep; 10(5):416-21. PubMed ID: 20595818
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of liver metastases from colorectal cancer patients.
Sayagués JM; Corchete LA; Gutiérrez ML; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvis L
Oncotarget; 2016 Nov; 7(45):72908-72922. PubMed ID: 27662660
[TBL] [Abstract][Full Text] [Related]
15. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.
Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallbohmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
Int J Cancer; 2006 Aug; 119(3):522-6. PubMed ID: 16572420
[TBL] [Abstract][Full Text] [Related]
16. Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis.
Shimamoto Y; Nukatsuka M; Takechi T; Fukushima M
Int J Mol Med; 2016 Feb; 37(2):319-28. PubMed ID: 26676887
[TBL] [Abstract][Full Text] [Related]
17. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.
Uchida K; Danenberg PV; Danenberg KD; Grem JL
BMC Cancer; 2008 Dec; 8():386. PubMed ID: 19105824
[TBL] [Abstract][Full Text] [Related]
19. Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion.
Smith JJ; Chatila WK; Sanchez-Vega F; Datta J; Connell LC; Szeglin BC; Basunia A; Boucher TM; Hauser H; Wasserman I; Wu C; Cercek A; Hechtman JF; Madden C; Jarnagin WR; Garcia-Aguilar J; D'Angelica MI; Yaeger R; Schultz N; Kemeny NE
Cancer Med; 2019 Nov; 8(15):6538-6548. PubMed ID: 31503397
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximab.
Barbier A; Domont J; Magné N; Goldmard JL; Genestie C; Hannoun C; Vaillant JC; Bellanger A; Khayat D; Capron F; Spano JP
Bull Cancer; 2010 Feb; 97(2):E9-E15. PubMed ID: 20085858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
